These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2892776)

  • 1. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout.
    Ferns GA; Lanham J; Dieppe P; Galton DJ
    Hum Genet; 1988 Jan; 78(1):55-9. PubMed ID: 2892776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins AI and AII.
    Rao SN; Magill PJ; Miller NE; Lewis B
    Clin Sci (Lond); 1980 Nov; 59(5):359-67. PubMed ID: 7428302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of apoprotein AI gene and observation on DNA polymorphism of apoprotein AI/CIII gene-loci in genomic library from a liver of Chinese.
    Xu HJ; Zhou HY; Hu SX; Pan XR
    Chin Med J (Engl); 1989 Mar; 102(3):169-73. PubMed ID: 2569382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.
    Ferns GA; Shelley CS; Stocks J; Rees A; Paul H; Baralle F; Galton DJ
    Hum Genet; 1986 Nov; 74(3):302-6. PubMed ID: 2877939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population.
    Anderson RA; Burns TL; Lee J; Swenson D; Bristow JL
    Atherosclerosis; 1989 Jun; 77(2-3):227-37. PubMed ID: 2751755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects.
    Chamberlain JC; Thorn JA; Oka K; Galton DJ; Stocks J
    Atherosclerosis; 1989 Sep; 79(1):85-91. PubMed ID: 2803349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid (DNA) polymorphism in the apolipoprotein AI gene: a study in a Japanese population.
    Aburatani H; Matsumoto A; Itoh H; Murase T; Takaku F; Itakura H
    Jpn J Med; 1988 Feb; 27(1):56-9. PubMed ID: 2896804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoprotein pattern in normolipemic peripheral vascular disease.
    Mannarino E; Siepi D; Pistola L; Pasqualini L
    Angiology; 1988 Jun; 39(6):555-8. PubMed ID: 3377274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of
    Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA polymorphisms around the apo AI gene in normal and hyperlipidaemic individuals selected for a twin study.
    Kessling AM; Berg K; Mockleby E; Humphries SE
    Clin Genet; 1986 Jun; 29(6):485-90. PubMed ID: 3017614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: a genetic determinant of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus.
    Renard E; Dupuy AM; Monnier L; Crastes de Paulet A
    Diabet Med; 1991 May; 8(4):354-60. PubMed ID: 1677323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
    Buzza M; Fripp Y; Mitchell RJ
    Ann Hum Biol; 2001; 28(5):481-90. PubMed ID: 11572515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
    Wick U; Witt E; Engel W
    Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia.
    Carlson LA; Ballantyne D
    Atherosclerosis; 1976; 23(3):563-8. PubMed ID: 178329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
    Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M
    Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis.
    Ferns GA; Galton DJ
    Hum Genet; 1986 Jul; 73(3):245-9. PubMed ID: 3015769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout.
    Chang SJ; Tsai PC; Chen CJ; Lai HM; Ko YC
    Rheumatology (Oxford); 2007 Nov; 46(11):1662-6. PubMed ID: 17938134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglycerides and apoproteins in toxemia of pregnancy.
    Yamaguchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1875-82. PubMed ID: 3209913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.